XML 63 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
OTHER CURRENT LIABILITIES (Details) (USD $)
Sep. 30, 2014
Dec. 31, 2013
Other Liabilities Disclosure [Abstract]    
Accrued clinical trial costs $ 2,385,094 $ 665,782
Accrued payroll and commission costs 603,525 941,313
Accrued vacation costs 434,614 256,920
Other accrued expenses 266,576 [1] 177,900 [1]
Allowance for wholesale distributor fees 245,232 306,303
Accrued legal and accounting expense 220,526 224,550
Accrued royalties 164,707 52,188
Allowance for coupons and returns 97,890 126,233
Accrued rent 92,915  
Accrued financing costs   850,000
TOTAL OTHER CURRENT LIABILITIES $ 4,511,079 $ 3,601,189
[1] In June 2008, we declared and paid a special dividend of $0.40 per share of our common stock to all stockholders of record as of June 10, 2008, of which $41,359 remained unclaimed by certain shareholders at September 30, 2014 and December 31, 2013.